DoseOptics

BeamSite Research provides real-time video-rate imaging of radiation delivery and is designed for researchers. It is tripod-mountable, movable, and has customizable acquisition settings for imaging tests.

DoseOptics created BeamSite, a radiation visualization tool designed for clinical use to help address concerns among people receiving radiation.

Modern radiation oncology relies on multiple layers of precision, from imaging and treatment planning to immobilization and motion management. Yet despite these advances, one critical aspect of treatment has traditionally remained invisible during delivery itself: the radiation beam.

The article traces how Cherenkov imaging developed into BeamSite, a real-time clinical tool for radiation therapy. DoseOptics co-founder Brian Pogue discusses the science and development behind the tool.

More than 14 million cancer patients receive radiation therapy each year. While significant advancements continue to be made in radiotherapy, errors may still occur during the treatment process.

This article in Diagnostic Imaging discusses the use of DoseOptics systems for Cherenkov imaging by the NCCC at Dartmouth College, as highlighted in the International Journal of Radiation Oncology, Biology, Physics.

Daniel Alexander, PhD student at the Thayer School of Engineering, Dartmouth College, won first place at the NEAAPM Winter Meeting. His work uses C-Dose for Cherenkov light imaging of human head & neck radiotherapy delivery.

DoseOptics was selected as a finalist for the 2026 SPIE Prism Awards.

DoseOptics' BeamSite camera system received FDA 510(k) clearance. It uses Cherenkov light imaging to show real-time video of the radiation beam on the patient and lets clinical teams monitor treatment live.

The page introduces the company's team and Cherenkov imaging technology for radiation therapy.

The company offers product demos and a contact form for inquiries.

BeamSite is a Cherenkov imaging system for clinicians using radiation therapy.